<style>
    @media(max-width:450px){
        #table1 thead tr th:nth-child(1){padding: 15px 5px 15px 10px;}
        #table1 tbody tr td:nth-child(1){padding: 15px 5px 15px 10px;}
        #table2 thead tr th:nth-child(1){padding: 15px 5px 15px 15px;}
        #table2 thead tr th:nth-child(3){padding: 15px 5px;}
        #table2 tbody tr td:nth-child(1){padding: 15px 5px 15px 15px;}
        #table2 tbody tr td:nth-child(2){padding: 15px 5px;}
    }
</style>
<h1 id="abm-category-home-title">CRISPR Stable Knock-In Cell Line Generation</h1>
<nav id="abm-navbar" class="navbar navbar-fixed-top abm-navbar abm-affix abm-category-navbar-relative hidden-xs">
	<div class="abm-container-fluid">
		<div id="abmNavbar" class="collapse navbar-collapse abm-navbar-collapse">
			<ul class="nav navbar-nav navbar-6">
				<li><a href="#abm-category-section1">Overview</a></li>
				<li><a href="#abm-category-section2">Service Details</a></li>
				<li><a href="#abm-category-section3">Additional Info</a></li>
				<li><a href="#abm-category-section4">Related Products</a></li>
				<li><a href="#abm-category-section5">Documents &amp; FAQS</a></li>
				<li><a href="#abm-category-section7">Citations</a></li>
			</ul>
		</div>
	</div>
</nav>
<div id="abm-category-section1" class="abm-container-fluid">
	<div class="row">
		<div class="col-sm-8 col-xs-12">
			<p>From a single-nucleotide substitution to a fluorescent reporter tag - a CRISPR knock-in creates precise desired mutations in the genomic DNA at the desired locus or safe harbour site. <br /><br /> Trust <strong>abm</strong> to knock in your gene of interest in your chosen cell line using our CRISPR sgRNA lentiviral system. Just tell our dedicated and highly experienced team which gene to insert and where, and we’ll cover everything from the sgRNA and HDR template design, cloning, lentiviral packaging, and stable cell line generation for you! <br /><br /> Interested in a control? Be sure to ask us about Wild Type Control Cell Lines Expressing Cas9 for comparison in the same cellular lineage, similar to our many <a class="orange-link" href="/catalog/category/view/s/cas9-expressing-cell-lines/id/47/">Cas9 Expressing Stable Cell Lines</a>. <br /><br /></p>
			<b class="subtitle">Sample Knock-in Data</b>
			<div>
				<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/CRISPR-Custom-Knock-In-Service-Data-high-res.png" alt="Workflow" /></a></p>
			</div>
			<i>Fluorescence image of HEK293 cell line showing RFP knock-in using CRISPR Cas9-mediated homology-directed repair mechanism. <b>Left</b>: RFP knock-in at the AAVS1 (Safe-harbor site) locus. <b>Right</b>: RFP knock-in at a non-AAVS1 site (random insertion).</i> <br /><br />
			<p><a href="/crispr-stable-knock-in-cell-line-generation-inquiry" target="_blank"><button class="custom-service-inquire-button-normal" style="float: left;">Inquire</button></a></p>
		</div>
		<div class="col-sm-4  col-xs-12">
			<div class="mini-box2">
				<div class="banners">
					<div><a href="https://www.youtube.com/watch?v=PlVy1oupFxw"> <img src="/pub/media/catalog/customservice/custom_crispr_sgrna_lentiviral_vectors_&amp;_viruses/Resources_Introduction-to-CRISPR.png" alt="Introduction to CRISPR" width="100%" /> <br /> </a> <strong>How to perform a CRISPR Knockin Experiment</strong></div>
				</div>
				<br /> <span class="bluetext"><b>Additional Resources:</b></span>
				<ul class="grey-list grey-link">
					<li><a href="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/CRISPR-Knockin-Service-Case-Study.pdf" target="_blank">CRISPR Knock-in Service Case Study</a></li>
					<li><a href="https://www.abmgood.com/CRISPR-product-selector/product-selector-form.php" target="_blank">CRISPR Experimental Design Tool</a></li>
				</ul>
			</div>
		</div>
	</div>
</div>
<div id="abm-category-section2">
	<div class="abm-container-fluid">
		<div class="row">
			<div class="col-lg-8">
				<h3 class="abm-perfect-h3">Service Details</h3>
				<div>
					<table id="table1" class="bootstrap-table bootstrap-table-hover abm-service-table abm-perfect-table2">
						<thead>
							<tr>
								<th>Our Basic Package (C408) Includes</th>
								<th>Deliverables</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td>
									A. Target DNA Vector Creation
									<ul style="list-style-type: decimal; padding-left:20px;">
										<li>gRNA Design and Construction (2-4 gRNAs)</li>
										<li>Donor DNA Construction (knock-in or point mutation)</li>
									</ul>
									B. Cell Culture, Transfection, Optimization<br />C. Clonal Selection and Screening
									<ul style="list-style-type: decimal; padding-left:20px;">
										<li>KI Confirmation by PCR or Sequencing</li>
									</ul>
									D. Clonal expansion and cryopreservation
								</td>
								<td style="text-align: left; color: black;">Genetically Engineered Cell Line (up to 2 vials 1x106 cells/vial) and Custom Report</td>
							</tr>
						</tbody>
					</table>
				</div>
				<div>
					<table id="table2" class="bootstrap-table bootstrap-table-hover abm-service-table abm-perfect-table1">
						<thead>
							<tr>
								<th>Add&#8209;On&nbsp;Services</th>
								<th>Unit</th>
								<th>CAT.&nbsp;NO.</th>
								<th>PRICE</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td>WT Control Cell Line Expressing Cas9 for Comparison <i>(50% discount for academic customers if ordered with the basic package)</i></td>
								<td>1&nbsp;Cell&nbsp;Line</td>
								<td>C142</td>
								<td>$<span class="customServicePriceGeoIP">1590.00</span></td>
							</tr>
							<tr>
								<td>Additional Clones</td>
								<td>1&nbsp;Clone</td>
								<td>C143</td>
								<td>$<span class="customServicePriceGeoIP">250.00</span></td>
							</tr>
							<tr>
								<td>Additional Vials of Delivered Cells^^^</td>
								<td>1&nbsp;Vial</td>
								<td>C144</td>
								<td>$<span class="customServicePriceGeoIP">80.00</span></td>
							</tr>
							<tr>
								<td>Western Blot Validation Service (Up to 10 Clones Tested)<sup>##</sup></td>
								<td>1&nbsp;Service</td>
								<td>C145</td>
								<td>$<span class="customServicePriceGeoIP">975.00</span></td>
							</tr>
							<tr>
								<td>Off-Target Analysis by Whole Genome Sequencing</td>
								<td>Per&nbsp;Clone</td>
								<td>C146</td>
								<td>$<span class="customServicePriceGeoIP">4000.00</span></td>
							</tr>
							<tr>
								<td>Additional Rounds of Selection &amp; Screening by Sanger Sequencing</td>
								<td>1&nbsp;Screening</td>
								<td>C147</td>
								<td>$<span class="customServicePriceGeoIP">835.00</span></td>
							</tr>
							<tr>
								<td>HA Tag Validation (Up to 10 Clones)#</td>
								<td>1&nbsp;Service</td>
								<td>C191</td>
								<td>$<span class="customServicePriceGeoIP">150.00</span></td>
							</tr>
							<tr>
								<td>Cell Line Authentication:<br />STR Profiling of 1 WT Parental Cell Line &amp; 1 Knock-Out Cell Line Clone<br /><i>(50% discount if ordered with the basic package)</i></td>
								<td>1&nbsp;Service</td>
								<td>C287</td>
								<td>$<span class="customServicePriceGeoIP">150.00</span></td>
							</tr>
						</tbody>
					</table>
				</div>
				<p><a href="/crispr-stable-knock-in-cell-line-generation-inquiry" target="_blank"><button class="custom-service-inquire-button-normal" style="float: right;">Inquire</button></a></p>
				<br /><br />
				<div style="font-size: 13px; color: grey;">**Choose from HEK293, HEK293T, A549, HeLa, MDCK, A375, HepG2, HT1080 or U87MG. These cell lines are available as Cas-9 expressing versions or parental versions. Cas9 expressing version will be used by default. If the parental version is preferred, please request prior to order placement.<br /> #Customer is required to provide at least 2 million cells, 1L of propagation media/any special coated flasks if needed (if cells need DMEM or RPMI, <strong>abm</strong> will supply media). Also, the cell line must tolerate single cell cloning and display adequate transfection and transduction efficiency.<br /> ##100μg of pre-validated antibody needs to be provided by customer with appropriate positive control (preferably with supporting data).<br /> ^All “add on” services need to be indicated prior to order placement as the project design will need to be finalized prior to start of the service.<br /> ^^ Final Lead time may vary depending on actual growth rate of cell line while expanding from single cell.<br /> Please note that if the gene to be knocked-out may be essential to cell survival, it is up to the end-user to proceed with the services. <strong>abm</strong> is unable to guarantee cell survival in these cases and will only attempt to rescue the clones under these conditions. <strong>abm</strong> is not accountable for cell survival if rescuing the clones (instructions to be provided customers) is unsuccessful.</div>
			</div>
			<div class="col-lg-4"></div>
		</div>
	</div>
</div>
<div id="abm-category-section3" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Additional Info</h3>
			<b class="subtitle">Workflow</b><br /> The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system offers cutting edge RNA-Guided endonuclease technology for highly specific and customizable genome editing. With the use of a target sequence-specific guide RNA, as well as the highly specific and programmable CRISPR associated nuclease (Cas9), <strong>abm</strong> offers an efficient and targeted genome editing service with minimal off-target effects.
			<div><a href="https://www.abmgood.com/CRISPR-product-selector/product-selector-form.php"> <img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/CRISPR-KI-workflow-v3.png" alt="Workflow" /> </a></div>
			CRISPR can be used to knock-in genes, tags, markers and more. With <strong>abm</strong>’s custom CRISPR Knock-In Service, you simply need to describe the desired knock-in and select a cell line, we do the rest. <br /><br /> <b class="subtitle">Need help designing your experiment?</b><br />
			<div>
				<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/CRISPR-Product-Selector-Button-KB-06.png" alt="Workflow" /></a></p>
			</div>
			<div>
				<a class="collapsed" href="#collapseAOne" data-toggle="collapse" data-parent="#accordion"><b class="subtitle">Case Study</b><i class="fa fa-angle-down OrderAngleDown" style="padding-left: 0.4em; font-size: 3rem;"></i></a><br />
				<div id="collapseAOne" class="panel-collapse collapse" style="border-left: none;">
					<div>
						<strong>Using CRISPR to Knock-in Red Fluorescent Protein (RFP) gene into Human Embryonic Kidney Cells at the AAVS1 Safe Harbour Site</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>An expression cassette containing RFP and puromycin resistance genes (pAAVS1-RFP-DNR) was knocked into the AAVS1 Safe-harbor site in HEK293 cells using CRISPR targeted genome editing via the HDR pathway. Gene insertion at a Safe-harbour site allows stable gene expression without any adverse effects on the fitness of the engineered cells.</li>
							<li>Genomic PCR confirmed Knocked-in RFP integration at AAVS1 Safe-harbor locus.</li>
							<li>RFP expression was confirmed in cells by fluorescence microscopy.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/HDR-pathway.png" alt="Workflow" /></a></p>
						</div>
						<i><b>Figure 1.</b> CRISPR Knock-in requires expression of Cas9 and sgRNA to produce a double-stranded break. The repair template, shown here as pAAVS1-RFP-DNR, is used by the cell to repair the break using homologous recombination. The desired gene and selection marker (RFP and puromycin) included between the homology arms on the repair template will be integrated into the genome.</i> <strong>Phase #1: Construction and Delivery of sgRNA, Cas9 and Repair Template</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>A sgRNA was designed against the human AAVS1 Safe-harbor locus.</li>
							<li>Software analysis was performed to ensure the sgRNA had no predicted off targets binding sites. The selected sgRNA design, along with the CMV-promoter driven Cas9 gene, was cloned into pCas-Guide to make pCas-Guide-AAVS1 (Figure 2).</li>
							<li>The pAAVS1-RFP-DNR donor plasmid was designed to contain the RFP-puromycin expression cassette, flanked on either side by homology arms of 600 bp (Figure 2).</li>
							<li>HEK293 cells were co-transfected with both plasmids using DNAfectin transfection reagent.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/pCas-Guide-AAVS1-01.png" alt="Workflow" /></a></p>
						</div>
						<i><b>Figure 2.</b> Vector maps of pCas-Guide-AAVS1 and pAAVS1-RFP-DNR. pCas-Guide-AAVS1 is an all-in-one vector for co-expression of sgRNA and Cas9 in mammalian cells. Expression of sgRNA is driven by the U6 promoter, a strong constitutive Pol III promoter; while a CMV promoter drives the expression of the Cas9 enzyme. pAAVS1-RFP-DNR expresses puromycin resistance marker under the PGK promoter and RFP gene under the CMV promoter. The 5’ and 3’ AAVS1 homology arms (‘AAVS-Left’ and ‘AAVS-Right’) provide the cells with a template for Homology Directed Repair. </i><br /><br /> <strong>Phase #2: Dilution of the Donor Plasmid and Resistance Marker Selection</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>Transfected HEK293 cells were passaged ten times to dilute out the donor vector.</li>
							<li>After these passages puromycin was added to the media to select for cells with successful knock-in of the RFP-puromycin resistance cassette.</li>
							<li>After 3-4 weeks of selection, &gt;95% of HEK293 cells were expressing RFP.</li>
						</ul>
						<br />
						<ul class="cleanlist banners">
							<li class="col-sm-12 col-lg-6 abm-category-workflow center-div"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/AAVS1-bright-field-image.jpg" alt="abm RNA Sequencing" /></a></li>
							<li class="col-sm-12 col-lg-6 abm-category-workflow center-div"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/aavs1-rfp.png" alt="abm RNA Sequencing" /></a></li>
							<li class="col-sm-12 col-lg-6 abm-category-workflow center-div"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/Scrambled-RFP-bright-field.jpg" alt="abm RNA Sequencing" /></a></li>
							<li class="col-sm-12 col-lg-6 abm-category-workflow center-div" style="text-align: left;"><i><b>Figure 3.</b> After transfection, HEK293 cells were passaged ten times to dilute out the donor vector, then grown in the presence of puromycin for 4 weeks. <b>Top Left)</b> Cells transfected with both pCas-Guide-AAVS1 and pAAVS1-RFP-DNR were healthy after 4 weeks. <b>Top Right)</b> Over 95% of these cells imaged expressed RFP. <b>Bottom Left)</b> Control cells not transfected with the vectors died after puromycin treatment.</i></li>
						</ul>
						<div class="row"></div>
						<br /><br /> <strong>Phase #3: Confirmation of Knock-in by Genomic PCR</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>To confirm knock-in of RFP in the genomic DNA, a primer pair was designed with Primer 1 targeting the 5’ homology arm upstream of RFP and Primer 2 targeting within the RFP-Puromycin resistance cassette.</li>
							<li>PCR product of 1.1 kb indicates successful knock-in at AAVS1 site; absence of PCR amplification indicates unsuccessful cassette insertion (Figure 4).</li>
							<li>No PCR amplification was seen in the control cells (‘WT cell’) since Primer 2 could not anneal to the genomic DNA.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/CRISPR-KI-Service-genomic-pcr.png" alt="Workflow" /></a></p>
						</div>
						<i><b>Figure 4.</b> Genomic PCR was used to confirm the knock-in of RFP. In edited cells, both primer 1 and primer 2 can bind, resulting in a 1.1 kb PCR product. No PCR product is formed in WT cells as primer 2 cannot anneal to the genomic DNA.</i>
					</div>
				</div>
			</div>
			<div>
				<a class="collapsed" href="#collapseATwo" data-toggle="collapse" data-parent="#accordion"><b class="subtitle">Additional Information &amp; MTA</b><i class="fa fa-angle-down OrderAngleDown" style="padding-left: 0.4em; font-size: 3rem;"></i></a><br />
				<div id="collapseATwo" class="panel-collapse collapse" style="border-left: none;">Orders of this service are subjected to the completion of a signed Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at <a class="orange-link" href="technical@abmgood.com">technical@abmgood.com</a>. The end user acknowledges that the Materials provided under abm’s MTA does not grant a license for commercial use or imply any ownership rights or any intellectual property rights relating to the Materials.<br /><br /> The cost of the basic service package starts at $15,000 for a single gene knock-in for diploid loci.</div>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section4" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Related Products</h3>
			<div class="col-xs-12 col-sm-6 col-md-6 col-lg-6">
				<div class="row">
					<div class="module">
						<ul class="htmlcontent-home">
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/CRISPR-Guaranteed-KO-Cell-Line-Generation.html"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="black-link" href="/CRISPR-Guaranteed-KO-Cell-Line-Generation.html">Guaranteed CRISPR Knockout Cell Line Generation Service</a></div>
									</div>
								</div>
							</li>
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/CRISPR-Bacterial-Genome-Editing.html"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="black-link" href="/CRISPR-Bacterial-Genome-Editing.html">CRISPR Bacterial Genome Editing Service</a></div>
									</div>
								</div>
							</li>
						</ul>
					</div>
				</div>
			</div>
			<div class="col-xs-12 col-sm-6 col-md-6 col-lg-6">
				<div class="row">
					<div class="module">
						<ul class="htmlcontent-home">
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/CRISPR-Gene-Deletion-CRISPR-miRNA-lncRNA-Knockout-Service.html"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="black-link" href="/CRISPR-Gene-Deletion-CRISPR-miRNA-lncRNA-Knockout-Service.html">CRISPR Gene Deletion and miRNA/lncRNA Knockout Service</a></div>
									</div>
								</div>
							</li>
							<li class="col-xs-6 col-sm-6 col-md-6"></li>
						</ul>
					</div>
				</div>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section5" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Documents</h3>
			<div>
				<ul class="cleanlist">
					<li><img src="/pub/media/catalog/category/imgs/perfect_page/PDF.png" /> <a class="black-link doclinks" href="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/C408 CRISPR Stable Knock-In Service Request Form mar 14.pdf">CRISPR Knock-in Service Request Form</a></li>
					<li><img src="/pub/media/catalog/category/imgs/perfect_page/PDF.png" /> <a class="black-link doclinks" href="/pub/media/catalog/customservice/crispr-stable-knock-in-cell-line/CRISPR-Knockin-Service-Case-Study.pdf">CRISPR Knock-in Service Case Study</a></li>
				</ul>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section6" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">FAQs</h3>
			<table>
				<tbody>
					<tr>
						<td style="padding: 8px 0; width: 37px;"><a href="#collapseOne" data-toggle="collapse" data-parent="#accordion"> <i class="fa fa-angle-down OrderAngleDown"></i> </a></td>
						<td><a href="#collapseOne" data-toggle="collapse" data-parent="#accordion"><b class="customfaq black-link">What should customers provide for this service?</b></a></td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td>
							<div id="collapseOne" class="panel-collapse collapse">
								<div class="abm-perfect-faqs-text">Please supply the cells for this service. For frozen cells, please ship at least 2 vials (at least 10^6 each) on dry ice. An alternative method is to send us two T25 flask of live cells per sample, at 90% confluency. The flasks should be filled with complete medium without any air bubbles and at room temperature. Please ensure that the sterilization procedure is strictly observed. To avoid delays over the weekend, we recommend shipping the cells on a Monday or a Tuesday. Frozen cells are preferred over live cells. If your cell line already contains an antibiotic resistance marker, please specify. Our vectors have puromycin resistance by default. If your cells require medium other than DMEM and RPMI, we will also require 1L of the specified medium and any applicable growth factors or supplements to be provided by you for the project. Please submit all components of the complete media (e.g. if growth factors, cytokines etc. are applicable) individually to eliminate potential degradation of components in the media during transit. Kindly include instructions for making the complete media in your shipment. Additionally, please provide at least 5 x coated 6-well plates and 10 x T25 flasks if the cells require specially treated culture vessels. Once you have shipped your cells, please forward us the tracking number for custom clearance. Information on how to ship cell samples to abm can be found on our support page: https://www.abmgood.com/Technical-Support.html Please place an order first prior to submitting your samples. All samples received must have the order confirmation number indicated. Any samples received without this piece of information will be disposed off immediately upon receipt to ensure that all customer information is held in strict confidence.</div>
							</div>
						</td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td style="padding: 8px 0; width: 37px;"><a href="#collapseTwo" data-toggle="collapse" data-parent="#accordion"> <i class="fa fa-angle-down OrderAngleDown"></i> </a></td>
						<td><a href="#collapseTwo" data-toggle="collapse" data-parent="#accordion"><b class="customfaq black-link">Can this service be performed for canine derived cells?</b></a></td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td>
							<div id="collapseTwo" class="panel-collapse collapse">
								<div class="abm-perfect-faqs-text">Yes, we can use sgRNA targeting canine genome to make stable KO cell lines. Please provide the specific cell medium for canine cell culture.</div>
							</div>
						</td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td style="padding: 8px 0; width: 37px;"><a href="#collapseThree" data-toggle="collapse" data-parent="#accordion"> <i class="fa fa-angle-down OrderAngleDown"></i> </a></td>
						<td><a href="#collapseThree" data-toggle="collapse" data-parent="#accordion"><b class="customfaq black-link">What information should I provide to get a quote?</b></a></td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td>
							<div id="collapseThree" class="panel-collapse collapse">
								<div class="abm-perfect-faqs-text">Please complete the Service Questionnaire form under the documents section above and email to quotes@abmgood.com.</div>
							</div>
						</td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td style="padding: 8px 0; width: 37px;"><a href="#collapseFour" data-toggle="collapse" data-parent="#accordion"> <i class="fa fa-angle-down OrderAngleDown"></i> </a></td>
						<td><a href="#collapseFour" data-toggle="collapse" data-parent="#accordion"><b class="customfaq black-link">Will CRISPR keep cutting the chromosome after the gene is edited?</b></a></td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td>
							<div id="collapseFour" class="panel-collapse collapse">
								<div class="abm-perfect-faqs-text">CRISPR is sensitive to mismatches, so it is unlikely the CRISPR will keep cutting the chromosome after the gene is edited.</div>
							</div>
						</td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td style="padding: 8px 0; width: 37px;"><a href="#collapseFive" data-toggle="collapse" data-parent="#accordion"> <i class="fa fa-angle-down OrderAngleDown"></i> </a></td>
						<td><a href="#collapseFive" data-toggle="collapse" data-parent="#accordion"><b class="customfaq black-link">How can you detect a mutation if there is no selection (by PCR using primers flanking the modified site or the T7 endonuclease I assay)?</b></a></td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td>
							<div id="collapseFive" class="panel-collapse collapse">
								<div class="abm-perfect-faqs-text">Yes, that is one method used. Other methods include Sanger sequencing, and Western Blot if the antibody is provided by the customer.</div>
							</div>
						</td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td style="padding: 8px 0; width: 37px;"><a href="#collapseSix" data-toggle="collapse" data-parent="#accordion"> <i class="fa fa-angle-down OrderAngleDown"></i> </a></td>
						<td><a href="#collapseSix" data-toggle="collapse" data-parent="#accordion"><b class="customfaq black-link">Can you offer this service in bacterial cells?</b></a></td>
					</tr>
				</tbody>
			</table>
			<table>
				<tbody>
					<tr>
						<td>
							<div id="collapseSix" class="panel-collapse collapse">
								<div class="abm-perfect-faqs-text">Yes, please visit our CRISPR Bacterial Genome Editing Service page for more information.</div>
							</div>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section7" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Citations</h3>
			<div>
				<table>
					<tbody>
						<tr>
							<td><span class="citations-num"><a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038/ncomms9371">01</a></span></td>
							<td>Kang, Y. J. et al. "Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling." Nat. Commun. (2015) 6:8371 <a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038/ncomms9371">doi: 10.1038/ncomms9371</a></td>
						</tr>
						<tr>
							<td><span class="citations-num"><a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1940-6207.CAPR-15-0338">02</a></span></td>
							<td>Jiang, G. et al. "Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis." Cancer Prev Res. Published Online First April 14, 2016.<a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1940-6207.CAPR-15-0338">doi: 10.1158/1940-6207.CAPR-15-0338</a></td>
						</tr>
						<tr>
							<td width="5%"><span class="citations-num"><a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1136/gutjnl-2015-309359">03</a></span></td>
							<td width="95%">Okugawa, Y. et al. "Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer." Gut (2015)<a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1136/gutjnl-2015-309359">doi:10.1136/gutjnl-2015-309359</a></td>
						</tr>
					</tbody>
				</table>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>